Pharmacy Quality Alliance | Strategic Alliance Partners

Awards Honor Excellence and Improvement in Overall CMS Medicare Part D Star Ratings and PQA Medication Measures.

Four New Members from Diverse Health Care Professions, Organizations and Industries Join Board

PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models

Pilot Will Evaluate Measure Concepts and Data Exchange in Value-Based Arrangements

Event will share patient, specialty pharmacy, pharmaceutical industry and payer perspectives

Call Developed as Part of National Initiative with Stakeholder Input

Awards Recognize the Association Community’s Economic and Societal Contributions

Low measure rates and minimal opportunity for improvement informed retirement vote

Analysis Will Study Effects of IRA Provisions to Improve Access to Basal Insulin

Aligning community pharmacy interventions with top-down findings, payers’ population health priorities, and identified unmet needs can help develop a sustainable pathway.

As value-based health care models become more widespread, these types of interventions will be important to demonstrate the value of pharmacist-embedded HSSPs.

Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism.

This is an exciting opportunity for all organizations involved.

This episode highlights strategies for pharmacists and pharmacies to address social determinants of health barriers through leveraging PQA's SDOH Resource Guide.

The third edition of the Pharmacy Quality Alliance resource guide includes 40 total SDOH services and 8 new services, as well as 10 initiative updates from the previous 2 editions.

Guide Highlights Key Themes for Success and Eight New Services

Seven New Members from Diverse Health Care Professions, Organizations and Industries Join Board

A Health Plan Measure to Assess Adherence or Persistence to Oral Anticancer Medications Is Top Priority.

Participants Will Attend PQA Annual Meeting, Have Access to More Than 20 Hours of Training.

Survey shows pharmacies could implement more point-of-care testing and have a large pool of willing participants.

There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.

PQA course provides an overview of how to build the best HIV treatment regimen and assess treatment outcomes.

The Pharmacy Quality Alliance developed the “Medication Access Framework for Quality Measurement” to address the social determinants of health that hinder patient medication access and contribute to poor health outcomes.

Concepts could be used in payer-pharmacy value-based arrangements.

The goal of this year’s competition was to propose a technology-driven solution to address pandemics, mental health, or social determinants of health (SDOH).

Pharmacy Times® interviewed Micah Cost, PharmD, MS, who was recently selected as the new chief executive officer of PQA, on his plans for the future of the organization.